Search
for
Sort by
Research 391–420 of 1000+
- Drug-induced hair pigmentation: Clinical perspectives and updates
- A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Ottawa, Ontario, Canada, February 13–16, 2013
- TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- GC-MS Fatty Acid Profile and In silico Studies of Telfairia occidentalis Hook f. (Fluted Pumpkin) and Sphenostylis stenocarpa (African Yam bean) Seeds Oil on Human 5 Alpha Reductase II
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
- Switching JAK inhibitors: evaluating baricitinib’s effectiveness in alopecia areata after tofacitinib failure
- Treatment Response to JAK Inhibitors in Long-standing Alopecia Areata (≥8 Years): A Real-world Observational Study
- Exploring novel management options for alopecia areata
- An ERK-dependent molecular switch antagonizes fibrosis and promotes regeneration in spiny mice ( <i>Acomys</i> )
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo
- The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
- Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- Ivarmacitinib stimulates hair regrowth in severe alopecia areata
- Alopecia Areata: JAK Inhibitors—PRP and Exosomes
- Abrocitinib in the Treatment of Severe Alopecia Areata in a Pediatric Patient: A Case Report
- ADVERSE EFFECTS OF RITLECITINIB IN ADULTS AND ADOLESCENTS WITH ALOPECIA AREATA: A LITERATURE REVIEW
- Response of alopecia areata of the beard to oral tofacitinib
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Review of Baricitinib in the Treatment of Alopecia Areata.